✦ LIBER ✦

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 1: Synthesis of the Key Intermediate 2,3,4,5-Tetrahydro-4-methyl-3-oxo-1 H -1,4-benzodiazepine-2-acetic Acid Methyl Ester, SB-235349

✍ Scribed by Andrews, Ian P.; Atkins, Richard J.; Breen, Gary F.; Carey, John S.; Forth, Michael A.; Morgan, David O.; Shamji, Amin; Share, Andrew C.; Smith, Stephen A. C.; Walsgrove, Timothy C.; Wells, Andrew S.

Book ID: 126165915
Publisher: American Chemical Society
Year: 2003
Tongue: English
Weight: 101 KB
Volume: 7
Category: Article
ISSN: 1083-6160
DOI: 10.1021/op034024c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Development of a Manufacturing Route

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A

✍ Atkins, Richard J.; Banks, Adam; Bellingham, Richard K.; Breen, Gary F.; Carey, 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 239 KB

A Practical and Robust Process to Produc

A Practical and Robust Process to Produce SB-214857, Lotrafiban, ((2 S )-7-(4,4 ‘ -Bipiperidinylcarbonyl)-2,3,4,5-tetrahydro-4-methyl-3-oxo-1 H -1, 4-Benzodiazepine-2-acetic Acid) Utilising an Enzymic Resolution as the Final Step

✍ Walsgrove, Timothy C.; Powell, Lawson; Wells, Andy 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 48 KB

A practical synthesis of (S) 3-tert-Buto

A practical synthesis of (S) 3-tert-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-Mimetic for caspase-1 (ICE) inhibitors

✍ David J. Lauffer; Michael D. Mullican 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

ChemInform Abstract: A Practical Synthes

ChemInform Abstract: A Practical Synthesis of (S) 3-tert-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1 -acetic Acid Methyl Ester as a Conformationally Restricted Dipeptido-Mimetic for Caspase-1 (ICE) Inhibitors.

✍ David J. Lauffer; Michael D. Mullican 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 38 KB 👁 1 views

Development of a Scalable Process for 1-

Development of a Scalable Process for 1-(3,5-Dichlorophenyl)-5-iodo-3-methyl- (4-methylbenzyl)-1 H -imidazo[1,2- a ]imidazol-2-one: A Key Intermediate for the Synthesis of LFA-1 Inhibitors

✍ Frutos, Rogelio P.; Eriksson, Magnus; Wang, Xiao-Jun; Byrne, Denis; Varsolona, R 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 79 KB

Development of a Practical Synthesis of

Development of a Practical Synthesis of the Progesterone Receptor Antagonist 4-{[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy}-2,6-dimethylbenzonitrile

✍ Bradley, Paul A.; de Koning, Pieter D.; Johnson, Patrick S.; Lecouturier, Yann C 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 246 KB